Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Iamgold Corporation (IAG) - free report >>
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Iamgold Corporation (IAG) - free report >>
Image: Bigstock
Best Momentum Stocks to Buy for October 14th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, October 14th:
IAMGOLD Corporation (IAG - Free Report) : This intermediate gold producer has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 30.8% over the last 60 days.
Iamgold Corporation Price and Consensus
Iamgold Corporation price-consensus-chart | Iamgold Corporation Quote
IAMGOLD’ shares gained 17.2% over the last three months compared with the S&P 500’s advance of 3.2%. The company possesses a Momentum Score of A.
Iamgold Corporation Price
Iamgold Corporation price | Iamgold Corporation Quote
DiaMedica Therapeutics Inc. (DMAC - Free Report) : This clinical stage biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 7.9% over the last 60 days.
DiaMedica Therapeutics, Inc. Price and Consensus
DiaMedica Therapeutics, Inc. price-consensus-chart | DiaMedica Therapeutics, Inc. Quote
DiaMedica’s shares gained 18.7% over the last three months compared with the S&P 500’s advance of 3.2%. The company possesses a Momentum Score of A.
DiaMedica Therapeutics, Inc. Price
DiaMedica Therapeutics, Inc. price | DiaMedica Therapeutics, Inc. Quote
HIVE Digital Technologies Ltd. (HIVE - Free Report) : This miner and seller of digital currencies has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 47.2% over the last 60 days.
HIVE Digital Technologies Ltd. Price and Consensus
HIVE Digital Technologies Ltd. price-consensus-chart | HIVE Digital Technologies Ltd. Quote
HIVE’s shares gained 17.8% over the last six months compared with the S&P 500’s advance of 14.9%. The company possesses a Momentum Score of B.
HIVE Digital Technologies Ltd. Price
HIVE Digital Technologies Ltd. price | HIVE Digital Technologies Ltd. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.